Barbara Hempstead

Barbara Hempstead completed her undergraduate work at Tufts Univerity. She went to receive M.D. and Ph.D. degrees at Washington University School of Medicine in St. Louis where she studied the biochemistry of the IgE receptor. Following training in Internal Medicine and Hematology at Cornell Medical College, Barabra did postdoctoral training in the lab of Dr. Moses Chao, where she was a member of the team that identified TrkA as a NGF receptor. Barbara is currently Professor in the Department of Medicine, and Co-Chief of the Division of Hematology and Medical Oncology at Weill Cornell Medical College. Her lab utilizes both genetic and biochemical approaches to study the roles of pro and mature neurotrophins in regulating neuronal development, response to injury and behavior.